1
|
Mettler C, Daguzan A, Lagouanelle MC, Briantais A, Ducros P, Laborde S, Gouiran S, Schleinitz N, Faucher B, Ebbo M. [Expectation of patients and caregivers about patient education for immune thrombocytopenia]. Rev Med Interne 2020; 42:3-10. [PMID: 33162191 DOI: 10.1016/j.revmed.2020.08.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 08/03/2020] [Accepted: 08/12/2020] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Immune thrombocytopenia (ITP) durably affects quality of life in patients. Patient education aims at improving their self-care and psychosocial skills, allowing them be more autonomous, to prevent avoidable complications, and to maintain or improve quality of life. The aim of this study was to assess patients' and caregivers' expectations regarding patient education in ITP. METHOD ITP Patients and caregivers were asked about topics that should be addressed in a patient education program through a digital anonymous survey. Their responses were analyzed both qualitatively and quantitatively. A double-blind keyword attribution of the answers was carried out by two physicians and then faced until consensus was found. RESULTS Thirty-eight ITP patients were included: 68% were less than 50 years old and 84% had chronic ITP. On the other hand, twenty-five caregivers were included. Caregivers raised more topics related to the cognitive domain than patients. The psychoaffective and motivational topics tended to be more represented in patients' responses. Only 53% of topics were mentioned by both patients and caregivers. CONCLUSION These discrepancies emphasize the differences between patients and caregivers' expectations regarding a patient education program in ITP, and thus the relevance of patient-caregiver co-construction of such programs.
Collapse
Affiliation(s)
- C Mettler
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France.
| | - A Daguzan
- Laboratoire de psychologie sociale (LPS), Aix-Marseille université, Aix-en-Provence, France; Service d'évaluation médicale, hôpital Conception, AP-HM, Marseille, France
| | - M-C Lagouanelle
- Laboratoire de psychologie sociale (LPS), Aix-Marseille université, Aix-en-Provence, France; Service d'évaluation médicale, hôpital Conception, AP-HM, Marseille, France
| | - A Briantais
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France
| | - P Ducros
- Association AMAPTI, 33, avenue Elléon, 13011 Marseille, France
| | - S Laborde
- Association O'CYTO, 33, avenue de Cajus, 33450 Saint-Loubes, France
| | - S Gouiran
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France
| | - N Schleinitz
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France
| | - B Faucher
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France
| | - M Ebbo
- Département de médecine interne, Centre de référence constitutif des cytopénies auto-immunes de l'adulte (CERECAI), hôpital de la Timone, Aix-Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France
| |
Collapse
|
2
|
Troin L, Mallet S, Lagouanelle MC, Scannapieco F, Lignon C, Gaudy-Marqueste C, Grob JJ, Richard MA. [Five years' experience of cosmetic camouflage of disfiguring skin disorders: Patient satisfaction]. Ann Dermatol Venereol 2019; 147:4-8. [PMID: 31831215 DOI: 10.1016/j.annder.2019.09.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2016] [Revised: 04/06/2019] [Accepted: 09/03/2019] [Indexed: 10/25/2022]
Abstract
INTRODUCTION Living with disfiguring disorders can impair the emotional well-being and relationships of patients as well as their social and professional life. Since 2010, courses in medical cosmetic correction for disfiguring diseases have been conducted at the dermatology department of the Timone University Hospital in Marseille and they form part of an educational program. The aim of this study was to assess the satisfaction of patients taking part in this program. PATIENTS AND METHODS This is a retrospective study of 55 patients taking part in make-up sessions from January 2010 to December 2014 and subsequently completing a questionnaire. RESULTS The median patient age was 46 years with most being women (n=49, 89 %). They presented pigmentary disorders (54.5 %), inflammatory diseases (27.3 %) and scars (18.2 %). 75 % of patients stated that they had improved their knowledge and 82 % remarked that the technique was personalized to their needs. The technique was considered as easy by 62 % and reproducible by 87 % of patients. 55 % of patients considered that cosmetic camouflage improved their quality of life and 56 % stated that it helped them accept the gaze of others. CONCLUSION In our study skin camouflage appears easy to use and meets patient expectations.
Collapse
Affiliation(s)
- L Troin
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France.
| | - S Mallet
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - M-C Lagouanelle
- Service de santé publique hôpital de la conception, Aix-Marseille université, AP-HM, 13385 Marseille, France
| | - F Scannapieco
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - C Lignon
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - C Gaudy-Marqueste
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - J-J Grob
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - M-A Richard
- CEReSS-EA 3279, Dermatology Department, Research Center in Health Services and Quality of Life Aix-Marseille University, Universitary Hospital Timone, Assistance Publique-Hôpitaux de Marseille, AP-HM, 13385, Marseille, France
| |
Collapse
|